Daily Pivots: (S1) 1.3512; (P) 1.3551; (R1) 1.3605; More… Intraday bias in GBP/USD remains on the upside at this point. Firm break of 61.8% retracement of 1.3867 to 1.3158 at 1.3596 will extend the rise Read more…
Daily Pivots: (S1) 158.43; (P) 158.98; (R1) 159.36; More… USD/JPY is still extending consolidations from 160.45 and intraday bias remains neutral. Outlook will stay bullish as long as 157.49 cluster support (38.2% retracement of 152.25 Read more…
The technical picture has turned “decidedly optimistic” as EUR/USD has reclaimed its 50, 100, and 200-day Moving Averages (MAs). Momentum oscillators on the H4 chart, with RSI at 70.5, suggest the move is overextended. Bulls Read more…
The US dollar remains under pressure, testing key support levels amid expectations of easing geopolitical tensions. The market continues to price in the possibility of renewed negotiations between the US and Iran, reducing demand for Read more…
EUR/USD started a fresh surge above 1.1740 and 1.1780. USD/CHF declined further and is now struggling below 0.7850. Important Takeaways for EUR/USD and USD/CHF Analysis Today The Euro started a major increase from 1.1665 against Read more…
Markets ECB President Lagarde yesterday gave an update on the central bank’s views on the current oil price shock. She did so on the sidelines of the IMF/Worldbank annual meetings. Lagarde suggested that the economy Read more…
In focus today Focus remains in the Middle East as the US’ blockade of Iranian ports continues, while details regarding the implementation are scarce. Overnight, China will release both Q1 GDP as well as the Read more…
Daily Pivots: (S1) 0.7801; (P) 0.7867; (R1) 0.7906; More…. Intraday bias in USD/CHF remains on the downside at this point. Fall from 0.8041 is in progress for 61.8% retracement of 0.7603 to 0.8041 at 0.7770. Read more…
The war premium is fading—and with it, the Dollar’s support. The greenback stayed under pressure in Asian session as oil prices retreated on renewed optimism that US-Iran talks could resume within the next two days. Read more…
The race to develop the next generation of medicines just got faster. At least, that is the bet Novo Nordisk is making. The Danish pharmaceutical company announced a strategic partnership with OpenAI on April 14, Read more…